MON-040 11-Oxygenated C19 Steroids in Polycystic Ovarian Syndrome

BACKGROUND: Polycystic ovarian syndrome (PCOS), an endocrine and reproductive disorder consisting of hyperandrogenism, menstrual dysfunction and ovarian changes, affects 6–20% of reproductive aged women worldwide. While hyperandrogenemia is traditionally determined by evidence of elevated testostero...

Descripción completa

Detalles Bibliográficos
Autores principales: Mody, Armaiti, Lodish, Maya Beth, Auchus, Richard Joseph, Huddleston, Heather Gibson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209052/
http://dx.doi.org/10.1210/jendso/bvaa046.551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209052/
http://dx.doi.org/10.1210/jendso/bvaa046.551

Ejemplares similares